, Tracking Stock Market Picks
Enter Symbol:
Market Vectors Emerging Markets Aggregate Bond E (EMAG) [hlAlert]

up 145.46 %

Emageon Inc. (EMAG) rated Buy

Posted on: Thursday,  Sep 6, 2007  3:25 PM ET by Avondale Partners

Avondale Partners rated Buy Market Vectors Emerging Markets Aggregate Bond E (AMEX: EMAG) on 09/06/2007, when the stock price was
$8.49. Since then, Market Vectors Emerging Markets Aggregate Bond E has gained 145.47% as of 08/26/2015's recent price of $20.84.
If you would have followed this Avondale Partners's recommendation on EMAG, you would have gained 145.46% of your investment in 2911 days.

Emageon's Intelligent Visual Medical System is an enterprise- level advanced visualization and infrastructure solution that allows physicians and healthcare professionals to manage, access and visualize medical content using relevant multi-specialty tools through a dynamic user interface. Delivered through Emageon's Enterprise Platform, hospital networks, clinics and imaging facilities are able to deploy a functionally rich, standards-based technology that permits faster access to future innovation while helping to lower the total cost of ownership.

Avondale’s research analysts are charged with producing high quality, independent, value-added, and timely investment analysis / advice. The firm’s strategy is to deemphasize maintenance research, and instead direct the overwhelming majority of our efforts on developing well-constructed, actionable recommendations, in part by leveraging proprietary networks of industry contacts. Avondale’s growing research department now totals 25 professionals. Senior analysts average 14 years of industry experience and are routinely recognized by a variety of nationally known rating entities. In the last two years, Avondale Analysts were named to the Wall Street Journal’s Best on the Street poll as well as’s Top Analyst Rankings.
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy